Non Invasive Prenatal Diagnosis for Monogenic Disorders (NIPD)

Non Invasive Prenatal Diagnosis for Monogenic Disorders (NIPD)2017-08-25T14:27:18+00:00

Non Invasive Prenatal Diagnosis for Monogenic Disorders (NIPD)

Description

Non-Invasive Prenatal Diagnosis (NIPD) is a DNA test on maternal blood to diagnose prenatally a limited number of monogenic disorders in the fetus:

  1. Cystic fibrosis
  2. Achondroplasia and thanatophoric dysplasia due to specific FGFR3 mutations
  3. Craniosynostosis due to specific FGFR2 mutations
  4. Apert syndrome
  5. Crouzon syndrome with acanthosis nigricans

More details on NIPD tests can be found in the different NIPD brochures.

Sample

10 ml blood in specific blood tubes provided by GENDIA is required from the mother.

Turnaround Time

?

Price

The price of the NIPD tests varies between 1400-1800 Euro.

Price List

Non Invasive Prenatal Diagnosis for Monogenic Disorders (NIPD)

Print Friendly, PDF & Email

GENDIA

Emiel Vloorsstraat 9, 2020 Antwerp

Phone: +32 3 303 08 01

Web: www.gendia.net